Skip to main content

Advertisement

SpringerLink
Log in

The perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Chemokines are peptides that function as chemoattractant cytokines in cell activation, differentiation and trafficking. Endothelin B receptor (ETBR) is a receptor for endothelin, which is known to function as a vasoconstrictor. In the present study, to clarify the immune escape mechanism of primary central nervous system lymphomas (PCNSLs), the expression of ETBR and of subsets of chemokines (CXCL12, 13) in 24 PCNSLs was investigated. CXCL12 was expressed by lymphoma cells in different resident brain cell populations in 22/24 cases. CXCL13 expression was identified in tumor cells in 19/24 cases, but was only expressed by tumor cells and by proliferating vascular endothelial cells. In addition, tumor-infiltrated lymphocytes (TILs) accumulated in areas with expression of chemokines, particularly of CXCL13. ETBR expression was detected in 12/24 cases. Positive ETBR cases were associated with a paucity of TILs, particularly of cytotoxic T cells, whereas negative ETBR cases were associated with an abundance of TILs. The combined data indicate that CXCL12 and CXCL13 up-regulation may be differently linked to the development of PCNSLs and to the accumulation of TILs. In addition, ETBR expression by lymphoma and endothelial cells may mediate trafficking of TILs, which may explain the immune escape processes of PCNSLs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Deckert M, Paulus W (2007) Malignant lymphomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) Pathology and Genetics of Tumours of the Nervous System. International Agency for Research on Cancer Press, Lyon, pp 188–192

    Google Scholar 

  2. Sugita Y, Tokunaga O, Nakashima A, Shigemori M (2004) SHP-1 expression in primary central nervous system B-cell lymphomas in immunocompetent patients reflects maturation stage of normal B cell counterparts. Pathol Int 54:659–666

    Article  CAS  PubMed  Google Scholar 

  3. Kucia M, Jankowski K, Reca R et al (2004) CXCR4-SDF1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 35:233–245

    Article  CAS  PubMed  Google Scholar 

  4. Teicher BA, Fricker SP (2007) CXCL12(SDF1)/CXCR4 pathway in cancer. Clin Cancer Res 16:2927–2931

    Article  Google Scholar 

  5. Lazarini F, Tham TN, Casanova P et al (2003) Role of the alpha-chemokine stromal cell-derived factor (SDF1) in the developing and mature central nervous system. Glia 42:139–148

    Article  PubMed  Google Scholar 

  6. Barbieri F, Bajetto A, Florio T et al (2010) Network in the development and progression of ovarian cancer: a potential novel pharmacological target. J Oncol 61:4961–4965

    Google Scholar 

  7. Singh S, Singh UP, Grizzle WE et al (2004) CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion. Lab Invest 84:1666–1676

    Article  CAS  PubMed  Google Scholar 

  8. Jiang Y, Wu X-H, Shi B et al (2006) Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103:226–233

    Article  CAS  PubMed  Google Scholar 

  9. Yasumoto K, Koizumi K, Kawashima A et al (2006) Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer. Cancer Res 66:2181–2187

    Article  CAS  PubMed  Google Scholar 

  10. Folkins C, Shaked Y, Man S et al (2009) Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 69:7243–7251

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Smith JR, Braziel RM, Paoletti S et al (2003) Expression of B-cell-attracting chemokine 1(CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood 101:815–821

    Article  CAS  PubMed  Google Scholar 

  12. Brunn A, Montesinos-Rongen M, Strack A et al (2007) Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma. Acta Neuropathathol 114:271–276

    Article  CAS  Google Scholar 

  13. Smith JR, Falkenhagen KM, Coupland SE et al (2007) Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol 127:633–641

    Article  CAS  PubMed  Google Scholar 

  14. Jahnke K, Coupland SE, Na IK et al (2005) Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma. Blood 106:384–385

    Article  CAS  PubMed  Google Scholar 

  15. Fischer L, Korfel A, Pfeiffer S et al (2007) CXCL13 and CXCL12 in central nervous system lymphoma patients. Clin Cancer Res 15:5968–5973

    Article  Google Scholar 

  16. Venetz D, Ponzoni M, Schiraldi M et al (2010) Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells. Int J Cancer Res 127:2300–2312

    Article  CAS  Google Scholar 

  17. Yanagisawa M, Kurihara H, Kimura S et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411–415

    Article  CAS  PubMed  Google Scholar 

  18. Inoue A, Yanagisawa M, Kimura S et al (1989) The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad of Sci USA 86:2863–2867

    Article  CAS  Google Scholar 

  19. Ahmed SI, Thompson J, Coulson JM, Woll PJ (2000) Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol 22:422–431

    Article  CAS  PubMed  Google Scholar 

  20. Rosano L, Varmi M, Salani D, Di Castro V, Spinella F, Natali PG, Bagnato A (2001) Endothelin-1 induces tumor proteinase activation and invasiveness of ovarian carcinoma cells. Cancer Res 61:8340–8346

    CAS  PubMed  Google Scholar 

  21. Kusuhara M, Yamaguchi K, Nagasaki K et al (1990) Production of endothelin in human cancer cell lines. Cancer Res 50:3257–3261

    CAS  PubMed  Google Scholar 

  22. Nelson JB, Chan-Tack K, Hedican SP et al (1996) Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer. Cancer Res 56:663–668

    CAS  PubMed  Google Scholar 

  23. Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G (2009) Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res 15:4521–4528

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Paolillo M, Barbieri A, Zanassi P, Schinelli S (2006) Expression of endothelins and their receptors in glioblastoma cell lines. J Neurooncol 79:1–7

    Article  CAS  PubMed  Google Scholar 

  25. Anguelova E, Beuvon F, Leonard N et al (2005) Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas. Brain Res Mol Brain Res 137:77–88

    Article  CAS  PubMed  Google Scholar 

  26. Buckanovich RJ, Facciabene A, Kim S et al (2008) Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 14:28–36

    Article  CAS  PubMed  Google Scholar 

  27. Sugita Y, Takase Y, Mori D, Tokunaga O, Nakashima A, Shigemori M (2007) Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival. J Neurooncol 82:249–256

    Article  CAS  PubMed  Google Scholar 

  28. Kiyasu J, Aoki R, Tanaka PY et al (2012) FOXP3+ regulatory and TIA-1+ cytotoxic T lymphocytes in HIV-associated Hodgkin lymphoma. Pathol In 62:77–83

    CAS  Google Scholar 

  29. Komatani H, Sugita Y, Arakawa F et al. (2009) Expression of CXCL12 on pseudopalisading cells and proliferating microvessels in glioblastomas: an accelerated growth factor in glioblastomas. Int J Oncol 34:665–672

  30. Ponzoni M, Berger F, Chassagne-Clement C et al (2007) Reactive perivascular T-cell infiltrate predicts survival in primary central nervous system B-cell lymphomas. Br J Haematol 138:316–323

    Article  CAS  PubMed  Google Scholar 

  31. Kandalaft LE, Facciabene A, Buckanovich RJ, Coukos G (2009) Endothelin B receptor, a new target in cancer immune therapy. Clin Cancer Res 15:4521–4528

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by JSPS KAKENHI Grant Number 24500427.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Pathology, Kurume University School of Medicine, Asahimachi 67, Kurume, Fukuoka, 830-0011, Japan

    Yasuo Sugita & Koichi Ohshima

  2. Department of Neurosurgery, Kurume University School of Medicine, Kurume, Japan

    Mizuhiko Terasaki, Shinji Nakashima & Motohiro Morioka

  3. Department of Surgical Pathology, Kurume University School of Medicine, Kurume, Japan

    Hideyuki Abe

Authors
  1. Yasuo Sugita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mizuhiko Terasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinji Nakashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Koichi Ohshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Motohiro Morioka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hideyuki Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yasuo Sugita.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugita, Y., Terasaki, M., Nakashima, S. et al. The perivascular microenvironment in primary central nervous system lymphomas: the role of chemokines and the endothelin B receptor. Brain Tumor Pathol 32, 41–48 (2015). https://doi.org/10.1007/s10014-014-0206-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-014-0206-0

Keywords

Search

Navigation